Pfizer CRZ 250 (Xalkori 250 mg)
Generic Name: crizotinib
Pill with imprint Pfizer CRZ 250 is Pink, Capsule-shape and has been identified as Xalkori 250 mg. It is supplied by Pfizer Inc..
Xalkori is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer CRZ 250
Xalkori
- Generic Name
- crizotinib
- Imprint
- Pfizer CRZ 250
- Strength
- 250 mg
- Color
- Pink
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-8140
More about Xalkori (crizotinib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.